New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
Prescribing rates have fallen slightly in the last two years, possibly because of growing caution in some countries about possible long-term effects.
But researchers said the use of the puberty-stalling hormones remained relatively high at a time when overseas jurisdictions were becoming increasingly restrictive about their use.
Inequities in health between Māori, the indigenous people of Aotearoa New Zealand, and non-Māori have been evident throughout the colonial history of the country. Read more
The New Zealand (NZ) Pae Ora (Healthy Futures) health reforms came into effect in July 2022 with the establishment of Health New Zealand (HNZ) (Te Whatu Ora) and the Māori Health Authority (MHA) (Te Aka Whai Ora) – the organisations charged for healthcare provision...
The Government has made much of the need to keep frontline services fully functioning, even when costs might be trimmed in the so-called “back office”. Read...
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI